Voluntary Surgical Terminations of Pregnancy: Comparison of the Hemorrhagic Risk Depending on the Term

Launched by UNIVERSITY HOSPITAL, TOULOUSE · May 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the safety and experiences of women undergoing surgical abortions between 14 and 16 weeks of pregnancy. With recent changes in French law allowing abortions up to 16 weeks, the trial aims to gather information about the risks involved, especially the risk of heavy bleeding, and to improve the support and information provided to patients. The goal is to help women make informed choices about their care during this emotionally challenging time.

To be eligible for this trial, participants must be women who are having a surgical abortion for a single pregnancy between 10 and 16 weeks. They should not be under legal protection or have declined to participate. During the trial, participants can expect to share their experiences, which will help healthcare providers understand how to better support women going through this process. This research is important because it can help improve the quality of care and information available to women considering a surgical abortion.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Woman treated for the performance of a surgical abortion between 10 and 16 weeks (dating by ultrasound)
• • Singleton pregnancy
• Exclusion Criteria:
• • Protected adult patient (guardianship, curatorship, safeguard of justice)
• • Refusal to participate expressed by the patient